Hospitality

Disinfectant/
Healthy Building Technologies

Corporate

Total

Income Statement for the three months ended June 30, 2023:

Net Sales

$

5,147,682

$

5,696,004

$

—

$

10,843,686

Cost of Goods Sold

$

4,134,884

$

4,299,108

$

—

$

8,433,992

Research and development

$

—

$

180,293

$

—

$

180,293

Stock based compensation

$

57,820

$

34,188

$

102,672

$

194,680

Selling, General and Administrative
expenses, less stock based compensation

$

1,206,113

$

2,988,000

$

533,326

$

4,727,439

Income Statement for the three months ended June 30, 2022:

Net Sales

$

4,169,112

$

1,738,534

$

—

$

5,907,646

Cost of Goods Sold

$

3,695,267

$

908,587

$

—

$

4,603,854

Research and development

$

—

$

82,049

$

—

$

82,049

Stock based compensation

$

30,149

$

37,800

$

44,502

$

112,451

Selling, General and Administrative
Expenses, less stock based compensation

$

1,195,460

$

2,033,074

$

690,230

$

3,918,764

Income Statement for the six months ended June 30, 2023:

Net Sales

$

11,229,055

$

10,269,114

$

—

$

21,498,169

Cost of Goods Sold

$

9,441,070

$

7,725,019

$

—

$

17,166,089

Research and development

$

—

$

369,503

$

—

$

369,503

Stock based compensation

$

114,674

$

70,364

$

199,771

$

384,809

Selling, General and Administrative
Expenses, less stock based compensation

$

2,239,702

$

5,871,973

$

1,690,014

$

9,801,689

Income Statement for the six months ended June 30, 2022:

Net Sales

$

5,578,362

$

3,685,374

$

—

$

9,263,736

Cost of Goods Sold

$

4,853,911

$

1,956,934

$

—

$

6,810,845

Research and development

$

—

$

141,363

$

—

$

141,363

Stock based compensation

$

116,160

$

60,086

$

224,204

$

400,450

Selling, General and Administrative
Expenses, less stock based compensation

$

1,854,548

$

3,818,284

$

1,059,159

$

6,731,991

Loss on impairment of goodwill

$

—

$

1,138,203

$

—

$

1,138,203